ZA976333B - Treatment of obesity - Google Patents

Treatment of obesity

Info

Publication number
ZA976333B
ZA976333B ZA976333A ZA976333A ZA976333B ZA 976333 B ZA976333 B ZA 976333B ZA 976333 A ZA976333 A ZA 976333A ZA 976333 A ZA976333 A ZA 976333A ZA 976333 B ZA976333 B ZA 976333B
Authority
ZA
South Africa
Prior art keywords
obesity
treatment
Prior art date
Application number
ZA976333A
Inventor
Paul Zev Zimmet
Roderick Alan Westerman
Gregory Collier
Original Assignee
Int Diabetes Inst
Paul Zev Zimmet
Roderick Alan Westerman
Gregory Collier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Diabetes Inst, Paul Zev Zimmet, Roderick Alan Westerman, Gregory Collier filed Critical Int Diabetes Inst
Publication of ZA976333B publication Critical patent/ZA976333B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA976333A 1996-07-18 1997-07-17 Treatment of obesity ZA976333B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO1085A AUPO108596A0 (en) 1996-07-18 1996-07-18 Treatment of obesity

Publications (1)

Publication Number Publication Date
ZA976333B true ZA976333B (en) 1998-07-23

Family

ID=3795401

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976333A ZA976333B (en) 1996-07-18 1997-07-17 Treatment of obesity

Country Status (3)

Country Link
AU (1) AUPO108596A0 (en)
WO (1) WO1998003175A1 (en)
ZA (1) ZA976333B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8393183B2 (en) 2007-05-07 2013-03-12 Whirlpool Corporation Fabric treatment appliance control panel and associated steam operations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438284A1 (en) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nicotine-containing depot plaster
DE3645036A1 (en) * 1986-11-18 1989-01-05 Forschungsgesellschaft Rauchen Nicotine-containing composition
US4943435A (en) * 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
US5573774A (en) * 1993-02-02 1996-11-12 Keenan; Robert M. Nicotine metabolites, nicotine dependence and human body weight
AU2703795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
MA23588A1 (en) * 1994-06-23 1995-12-31 Procter & Gamble TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
MA23587A1 (en) * 1994-06-23 1995-12-31 Procter & Gamble TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
AU2702795A (en) * 1994-06-23 1996-01-19 Procter & Gamble Company, The Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration

Also Published As

Publication number Publication date
AUPO108596A0 (en) 1996-08-08
WO1998003175A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
EG21382A (en) Treatment of water
GB9407135D0 (en) Treatment of osteoporosis
PL338082A1 (en) Methods of treating obesity
PL328831A1 (en) Combined treatment of osteoporosis
AU7772794A (en) Treatment of obesity
EP0795035A4 (en) Treatment of hides
GB9619492D0 (en) Novel treatment
ZA971958B (en) Treatment of cocoa
ZA976593B (en) Novel treatment
EP0724842A3 (en) Preparation for the treatment of obesity
GB9608657D0 (en) Novel treatment
ZA976333B (en) Treatment of obesity
EP0880468A4 (en) Bauxite treatment
GB9625795D0 (en) Novel treatment
AU3429697A (en) Treatment of obesity
GB9618290D0 (en) Treatment of diabetes
GB9603724D0 (en) Combinatyion therapy for the treatment of diabebes and obesity
AUPP039897A0 (en) Treatment of obesity
AUPO900197A0 (en) Treatment of obesity
AU2002301576A1 (en) Treatment of obesity
GB9612752D0 (en) Novel treatment
GB9622852D0 (en) Treatment of intimal hyperplasma
GB9602404D0 (en) Methods of treatment
GB9612603D0 (en) Treatment of biosolids
GB9604916D0 (en) Treatment of lead